Related Experiment Video
Updated: Oct 25, 2025

A Macrophage Reporter Cell Assay to Examine Toll-Like Receptor-Mediated NF-kB/AP-1 Signaling on Adsorbed Protein Layers on Polymeric Surfaces
Published on: January 7, 2020
Protein arginine methyltransferase 5 mediates THP-1-derived macrophage activation dependent on NF-κB in endometriosis
Xiaoshan Chai1, Xianqing Wu1, Ling He1
1Department of Obstetrics and Gynecology, The Second Xiangya Hospital of Central South University, Changsha, Hunan 410011, P.R. China.
Abstract:
Macrophage-induced inflammation is a major factor in the pathogenesis of endometriosis. The underlying mechanisms, however, remain largely unknown. TNF-α, IL-6, IL-10 and C-C motif chemokine 20 (CCL20) levels in endometrial extracts were determined using Luminex cytokine kits. Additionally, protein arginine methyltransferase 5 (PRMT5) levels were measured using reverse transcription-quantitative PCR and western blotting. IL-6 and IP-10 levels in cells were measured using ELISA kits. In the present study, it was revealed that PRMT5 expression at both the mRNA and protein levels in THP-1-derived macrophages was significantly decreased following treatment with serum or extracts of endometrium from patients with endometriosis in the presence of lipopolysaccharide, compared with that in control cells, suggesting a possible role for macrophage-derived PRMT5 in mediating the interaction between macrophages and endometrium in endometriosis. Mechanistically, macrophage PRMT5 expression was regulated in an NF-κB-dependent and Smad2/3-independent manner, indicating that PRMT5 is a downstream target of NF-κB. Importantly, macrophage-derived PRMT5 was required for macrophage activation in endometriosis, as evidenced by the PRMT5-dependent secretion of IL-6 and IFN-γ-induced protein 10 from THP-1-derived macrophages. The present study identified NF-κB-dependent PRMT5 as a novel regulator of macrophage activation in endometriosis. Targeting PRMT5 in macrophages may be a potential therapeutic strategy against endometriosis.
Insights
Protein arginine methyltransferase 5 (PRMT5) is crucial for macrophage activation in endometriosis. Targeting PRMT5 in macrophages offers a potential therapeutic strategy for endometriosis by regulating inflammation.
Area of Science:
- Immunology
- Molecular Biology
- Reproductive Medicine
Background:
- Macrophage-driven inflammation is central to endometriosis pathogenesis.
- The specific molecular mechanisms linking macrophages and endometriosis remain unclear.
- Understanding these mechanisms is key to developing effective treatments.
Purpose of the Study:
- To investigate the role of protein arginine methyltransferase 5 (PRMT5) in macrophage activation within the context of endometriosis.
- To elucidate the regulatory pathways controlling PRMT5 expression in macrophages.
- To assess the potential of targeting PRMT5 as a therapeutic strategy for endometriosis.
Main Methods:
- Quantification of cytokines (TNF-α, IL-6, IL-10, CCL20) in endometrial extracts using Luminex kits.
- Measurement of PRMT5 mRNA and protein levels via RT-qPCR and Western blotting.
- Assessment of IL-6 and IP-10 secretion using ELISA kits.
Main Results:
- PRMT5 expression was significantly reduced in macrophages treated with endometriosis patient samples.
- PRMT5 expression is regulated by NF-κB in a Smad2/3-independent manner.
- Macrophage-derived PRMT5 is essential for the secretion of IL-6 and IFN-γ-induced protein 10, indicating its role in macrophage activation.
Conclusions:
- NF-κB-dependent PRMT5 is identified as a novel regulator of macrophage activation in endometriosis.
- PRMT5 plays a critical role in mediating macrophage responses relevant to endometriosis.
- Targeting PRMT5 in macrophages presents a promising therapeutic avenue for endometriosis treatment.
Related Concept Videos
TGF - β Signaling Pathway
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...

